C. Li et al.
1
0.1 ppm; HRMS(EI ) calcd for C H N O Cl (M ), 324.0989; monitored by TLC. Then the solution was neutralized with a
35
1
2
14 17 4 3
3
7
1
17 4 3 3
found, 324.1014. calcd for C14H N O Cl (M ), 3 26.0960; found, saturated solution of NaHCO and extracted with dichloro-
3
1
26.0964; Anal. Calcd for C14
H
7.25, Found: C, 51.91; H, 5.15; N, 16.95.
17ClN
4
O
3
: C, 51.78; H, 5.28; N, methane, the combined extracts were dried over anhydrous
Na SO , filtered and concentrated in vacuo to give an oily residue.
2 4
1
Purification by silica gel chromatography using dichloromethane:
acetone (4:1, v/v) as an eluent giving 165 mg of a canary yellow
solid, yield 51%. mp= 149.0–150.01C; HNMR (400Mz, DMSO-
3
1
methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimida-
-((6-Chaloropyridin-3-yl)½ H2ꢃ-methyl)-5-propyloxy-7-
1
3
zo[1,2-a]pyridine (½ H2ꢃ-Paichongding)
d
7
4
6 1 2
):d 8.35 (d, J = 2.4 Hz, 1H), 7.81 (dd, J = 2.4 Hz, J = 8.4 Hz, 1H),
.51 (d, J = 8.4 Hz, 1H), 5.36–5.39 (s, 2H), 5.00 (d, J = 15.6Hz, 1H),
.68 (d, J = 15.6Hz, 1H), 3.57–3.73 (m, 4H), 1.94–2.04 (m, 4H) ppm;
To the above compound 6 (131 mg, 0.4 mmol) in dichloro-
methane was added propan-1-ol (0.84 mL, 11.25 mmol) and
hydrochloric acid (0.08 mL), the mixture was refluxed and stirred
for 36 h, then the solvent was removed and the residue was
purified by column chromatography (dichloromethane:ace-
tone = 4:1, v/v) affording a pure yellow solid in 55% yield.
1
mp = 130.2-131.91C; HNMR (400 Mz, CDCl
1
3
CNMR (400Mz, DMSO-d ):d 155.6, 149.7, 149.6, 139.7, 132.6,
6
1
24.5, 109.6, 87.0, 75.1, 51.2, 50.3, 46.6, 31.9,31.7 ppm; HRMS
35
1
ESI ) calcd for
1
Cl(M1H) , 323.0911; found,
(
C H N O
14 16 4 3
3
3
7
1
23.0912. calcd for C H N O Cl (M1H) , 325.0811; found,
3
325.0895. calcd for
1
4
16
4
3
5
1
ClNa(M1Na) , 345.0730;
C
14
H
16
N
4
O
N
3
3
):d 8.31–8.33 (m, 1H),
3
7
1
ClNa(M1Na) , 347.0701;
found, 345.0722. cacld for C14
found, 347.0692.
H
16
4
O
3
7.86 (dd, J = 8.4 Hz, 0.5H), 7.82 (dd, J = 2.4 Hz,
J = 8.2 Hz, 0.5H), 7.33 (dd, J = 0.8 Hz, J = 1.2 Hz, 0.5H), 7.31
1
= 2.4 Hz, J
2
1
2
2
1
2
(
(
1 2
dd, J = 0.8 Hz, J = 1.2 Hz, 0.5H), 4.88 (d, J = 15.2 Hz, 0.5H), 4.82
3
d, J = 15.2 Hz, 0.5H), 4.61–4.67 (m, 1H), 4.55 (dd, J
1
= 3.6 Hz, The chemical and radiochemical purities of ½ H2ꢃ-Paichongd-
3
J2 = 6.0 Hz, 0.5H), 4.50 (t, J = 3.6 Hz, 0.5H), 3.95–4.02 (m, 0.5H), ing and ½ H2ꢃ-Cycloxaprid
3
(
2
.81–3.86 (m, 0.5H), 3.64–3.72 (m, 1H), 3.35–3.59 (5H), 2.14–2.21
m, 0.5H), 1.99–2.01 (m, 1H), 1.75-1.82 (m, 0.5H), 1.54–1.65 (m,
H), 1.22–1.27 (d, J = 6.8 Hz, 0.5H), 1.23 (d, J = 6.8 Hz, 0.5H), 0.95
The chemical purity was determined by HPLC. HPLC condition:
Diamonsil C18 (2) 5 mm, 250 ꢂ 4.6 mm, solvent: acetonitrile/
3
water = (65:35, v/v) for [ H
1
2
]-Paichongding and (75:25, v/v)
(
t, J = 6.2 Hz, 0.5H), 0.92 (t, J = 6.2 Hz, 0.5H) ppm; HRMS(EI ) calcd
1
3
for [ H ]-Cycloxaprid, flow: 1 mL/min. The retention time of
3
3
5
1
Cl (M1) , 366.1459; found, 366.1487.
2
for C17
H
23
N
4
O
3
[
[
H ]-Paichongding was 6.87 min, 12.16 min for its isomers, and
2
3
3
]-Cycloxaprid was 6.44 min. The chemical purity of [ H
H
2
2
]-
]-Cycloxaprid was 98.7 and 98.4%,
3
5
-((6-Chloro-pyridin-3-yl)½ H2ꢃ-methyl)-7-nitro-11-oxa-2,5-
3
2
,6
3
Paichongding and [ H
respectively.
2
diaza-tricyclo[6.2.1.0 ]undec-6-ene (½ H2ꢃ-Cycloxaprid)
To a mixture of tetrahydro-2,5-dimethoxy-furan (0.48 mL,
.7 mmol) and [ H
The radiochemical purity was measured with HPLC-LSC
2
]-6-Cl-PMNI (259mg, 1.02mmol) in acetonitrile method, which is operated as follows: all the components were
3
3
(
3mL) was added hydrochloric acid (1.8mL, 1 mol/L), the resulting collected by flashing bottle after separation of labeled
0
solution was stirred at 351C for 4 h and the reaction was compounds by HPLC, the radioactivity of all the components(A )
O
3
NaB H
4
O
Cl
N
*
*
SOCl2
OH
Cl
Cl
N
Cl
N
O
3
NaB H
4
Cl
2
3
Cl
N
1
O N
S
S
O2N
2
*
NH2
*
N
H
N
NH
Cl
N
Cl
N
NH2
4
H N
2
[3
H2]-6-Cl-PMNI
N
Cl
H
*
N
N
H
*
Cl
N
5
3
Scheme 3. Preparation of [ H
3
]-6-Cl-PMNI with 6-chloronicotinoyl chloride (1) and NaB H
2
4
(Ã the label site).
www.jlcr.org
Copyright r 2011 John Wiley & Sons, Ltd.
J. Label Compd. Radiopharm 2011, 54 256–259